Skip to content
Trending storyDeveloping

Insilico Medicine launches inClinico Agent to predict clinical trial outcomes

1 article1 sourcesince Oct 27Last article

Overview

AISummary of 1 article

Insilico Medicine has launched inClinico Agent, an agentic AI system that predicts clinical trial outcomes, and says it is now available to industry partners.

The company reports an efficacy AUROC of 0.828 and a safety AUROC of 0.809. The system is built on more than 100,000 trial records and live ClinicalTrials.gov queries.

A head-to-head prospective benchmark against five frontier LLMs covered 3,235 ongoing Phase I–III trials, according to the company's announcement. The results of that benchmark are not included in the launch report.

Written by AI from the articles below · updated Oct 27, 5:42 PM ET

Check the sources:

Latest developmentOct 27, 7:50 AM ET
inClinico Agent predicts clinical trial outcomes with 0.828 efficacy AUROC

Article timeline

The articles in this story. Times are ET.

Oct 27
  1. Insilico MedicineX
    inClinico Agent predicts clinical trial outcomes with 0.828 efficacy AUROC

    AIinClinico Agent, an agentic AI system, predicts clinical trial outcomes with an efficacy AUROC of 0.828 and a safety AUROC of 0.809. It is built on over 100,000 trial records and live ClinicalTrials.gov queries. The system is now available to industry partners, and a head-to-head prospective benchmark against five frontier LLMs covered 3,235 ongoing Phase I–III trials.

    Video from @InSilicoMeds's post

Heat Trend

Current comparable heat
5
Peak comparable heat
8Oct 27, 6:00 PM ET
Change in past 24 hours
–

The trend compares only continuously observed participants, so its scope may be smaller than the current heat total. Hover or tap for hourly heat; use arrow keys with a keyboard.